Surviving a stroke is only the beginning. Preventing the next one is where the real clinical challenge lies—and for patients with non-cardioembolic stroke, the existing toolkit has long fallen short.

Join Drs. Geoff Barnes, Mike Sharma, and Valeria Caso as they explore:

• Stroke subtypes, recurrence risk, and the unique challenges of non-cardioembolic stroke and ESUS

• Why current treatment options have fallen short—and what may be next

• The advent of Factor XI inhibitors and what emerging data may mean for the future of secondary prevention

Tune in now and subscribe to Clot, Clot, Who's There? for more expert conversations bridging science, practice, and global perspectives in thrombosis, hemostasis, and vascular medicine.

• 00:00: Introduction & Stroke Subtypes

• 03:59: Recurrence Risk & Key Risk Factors

• 07:24: Current Treatment Strategies

• 10:54: ESUS & Limits of Anticoagulation

• 14:19: Moving Beyond Aspirin

• 16:26: Factor XI Inhibitors: Data & Future Directions

This episode was made possible through generous support from Bayer.